Atlas Venture Fund IX L.P. 13D/13G Filings for Cogent Biosciences, Inc. (COGT)

Atlas Venture Fund IX L.P. 13D and 13G filings for Cogent Biosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2022-01-25
11:32 am
Unchanged		2021-12-3113GCogent Biosciences, Inc.
COGT		Atlas Venture Fund IX L.P.916,196
2.300%		0
(Unchanged)		Filing
2021-02-02
1:02 pm
Purchase		2020-12-3113GCogent Biosciences, Inc.
COGT		Atlas Venture Fund IX L.P.916,196
8.080%		916,196increase
(New Position)		Filing